Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-center, Single-arm Clinical Study of Nanosecond Pulsed Field Ablation System in the Treatment of Paroxysmal Atrial Fibrillation Under the Guidance of 3-Dimensional Mapping System

NCT07586176 is registered in ClinicalTrials.gov with Shanghai Shangyang Medical Technology Co., Ltd. as lead sponsor.

NCT NCT07586176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07586176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-center, Single-arm Clinical Study of Nanosecond Pulsed Field Ablation System in the Treatment of Paroxysmal Atrial Fibrillation Under the Guidance of 3-Dimensional Mapping System
Lead sponsor
Shanghai Shangyang Medical Technology Co., Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 10, 2024
Completion date
September 30, 2026
Enrollment
152 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (paroxysmal), paroxysmal af, pulsed field ablation